Shannon M. Mumenthaler, Ph.D. - Publications

2008 University of California, Los Angeles, Los Angeles, CA 
Cell Biology, Oncology, Pathology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Liu X, Lukowski JK, Flinders C, Georgiadis R, Kim S, Mumenthaler S, Hummon AB. MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon Cancer Cell Cultures. Analytical Chemistry. PMID 30479121 DOI: 10.1021/acs.analchem.8b02151  0.44
2017 Liu X, Flinders C, Mumenthaler SM, Hummon AB. MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids. Journal of the American Society For Mass Spectrometry. PMID 29209911 DOI: 10.1007/s13361-017-1851-4  0.44
2016 Macklin P, Frieboes HB, Sparks JL, Ghaffarizadeh A, Friedman SH, Juarez EF, Jonckheere E, Mumenthaler SM. Progress Towards Computational 3-D Multicellular Systems Biology. Advances in Experimental Medicine and Biology. 936: 225-246. PMID 27739051 DOI: 10.1007/978-3-319-42023-3_12  0.68
2016 Juarez EF, Lau R, Friedman SH, Ghaffarizadeh A, Jonckheere E, Agus DB, Mumenthaler SM, Macklin P. Quantifying differences in cell line population dynamics using CellPD. Bmc Systems Biology. 10: 92. PMID 27655224 DOI: 10.1186/s12918-016-0337-5  0.68
2016 Garvey CM, Spiller E, Lindsay D, Chiang CT, Choi NC, Agus DB, Mallick P, Foo J, Mumenthaler SM. A high-content image-based method for quantitatively studying context-dependent cell population dynamics. Scientific Reports. 6: 29752. PMID 27452732 DOI: 10.1038/srep29752  0.68
2016 Yadav VK, Smith KS, Flinders C, Mumenthaler SM, De S. Significance of duon mutations in cancer genomes. Scientific Reports. 6: 27437. PMID 27272679 DOI: 10.1038/srep27437  0.68
2015 Yang-Kolodji G, Mumenthaler SM, Mehta A, Ji L, Tripathy D. Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 20: 313-22. PMID 26329528 DOI: 10.3109/1354750X.2015.1068865  0.68
2015 Mumenthaler SM, Foo J, Choi NC, Heise N, Leder K, Agus DB, Pao W, Michor F, Mallick P. The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Informatics. 14: 19-31. PMID 26244007 DOI: 10.4137/CIN.S19338  0.68
2015 Frieboes HB, Smith BR, Wang Z, Kotsuma M, Ito K, Day A, Cahill B, Flinders C, Mumenthaler SM, Mallick P, Simbawa E, Al-Fhaid AS, Mahmoud SR, Gambhir SS, Cristini V. Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma. Plos One. 10: e0129433. PMID 26061425 DOI: 10.1371/journal.pone.0129433  0.68
2014 Li K, Tavaré R, Zettlitz KA, Mumenthaler SM, Mallick P, Zhou Y, Marks JD, Wu AM. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments. Molecular Cancer Therapeutics. 13: 2607-17. PMID 25143449 DOI: 10.1158/1535-7163.MCT-14-0363  0.68
2013 Mumenthaler SM, D'Antonio G, Preziosi L, Macklin P. The Need for Integrative Computational Oncology: An Illustrated Example through MMP-Mediated Tissue Degradation. Frontiers in Oncology. 3: 194. PMID 23898463 DOI: 10.3389/fonc.2013.00194  0.68
2013 Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, Austin RH, Backman V, Bethel KJ, Bonneau R, Chen WC, Chen-Tanyolac C, Choi NC, Curley SA, Dallas M, ... ... Mumenthaler SM, et al. A physical sciences network characterization of non-tumorigenic and metastatic cells. Scientific Reports. 3: 1449. PMID 23618955 DOI: 10.1038/srep01449  0.68
2013 Foo J, Leder K, Mumenthaler SM. Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors. Evolutionary Applications. 6: 54-69. PMID 23396647 DOI: 10.1111/eva.12019  0.68
2011 Mumenthaler SM, Foo J, Leder K, Choi NC, Agus DB, Pao W, Mallick P, Michor F. Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Molecular Pharmaceutics. 8: 2069-79. PMID 21995722 DOI: 10.1021/mp200270v  0.68
2009 Mumenthaler SM, Ng PY, Hodge A, Bearss D, Berk G, Kanekal S, Redkar S, Taverna P, Agus DB, Jain A. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Molecular Cancer Therapeutics. 8: 2882-93. PMID 19825806 DOI: 10.1158/1535-7163.MCT-09-0293  0.68
2009 Bernstein HB, Wang G, Plasterer MC, Zack JA, Ramasastry P, Mumenthaler SM, Kitchen CM. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. Virology. 387: 59-66. PMID 19251297 DOI: 10.1016/j.virol.2009.01.044  0.68
2008 Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW. Disruption of arginase II alters prostate tumor formation in TRAMP mice. The Prostate. 68: 1561-9. PMID 18663728 DOI: 10.1002/pros.20816  0.68
2008 Mumenthaler SM, Yu H, Tze S, Cederbaum SD, Pegg AE, Seligson DB, Grody WW. Expression of arginase II in prostate cancer. International Journal of Oncology. 32: 357-65. PMID 18202758  0.68
Show low-probability matches.